You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

185 search results for: symposium

ERS 2023 | Adult Asthma <b>Symposium</b>: Mini Debate

expert video

ERS 2023 | Adult Asthma Symposium: Mini Debate

3 min

Pulmonology

Prof. Ian Pavord moderates a debate between Prof. Vibeke Backer and Dr. Francesca Puggioni about what a patient's lung function should be in order to be defined as achieving clinical remission in adult asthma.

ERS 2023 | Adult Asthma <b>Symposium</b>: Panel Discussion

expert video

ERS 2023 | Adult Asthma Symposium: Panel Discussion

9 min

Pulmonology

Profs. Ian Pavord and Vibeke Backer and Dr. Francesca Puggioni and audience members share their views on the proposed framework for clinical remission in severe asthma.

ERS 2023 | Pediatric Asthma <b>Symposium</b>: Patient Case Discussion

expert video

ERS 2023 | Pediatric Asthma Symposium: Patient Case Discussion

11 min

Pulmonology

Join pediatric asthma experts Prof. Giorgio Piacentini and Dr. Sharon Dell for an educational program on the topic of remission in pediatric asthma.

expert video

Emerging Clinical Data in Children With Atopic Dermatitis- Q&As

6 min

Dermatology

Explore the WCD 2023 ADVENT symposium’s insights into current and emerging treatment strategies for managing pediatric atopic dermatitis.

expert video

IL-4 and IL-13: Shared and Unique Roles in Atopic Dermatitis (AD) and Prurigo Nodularis (PN)

53 min

Dermatology

Highlights from the WCD 2023 ADVENT symposium, exploring the distinctions and shared elements of atopic dermatitis and prurigo nodularis.

expert video

The Neuroimmune Axis and Neuroinflammatory Mechanism of Pruritus

13 min

Dermatology

Insights from ESDR 2022 ADVENT symposium, examining the complex mechanisms that underlie pruritus in atopic dermatitis.

expert video

Interactions of Type 2 Inflammation on Epidermal Abnormalities: Barrier Dysfunction and Microbial Dysbiosis: Panel Discussion

5 min

Dermatology

Interactive panel discussion from ESDR 2022 ADVENT symposium, where experts answer hot topics straight from the audience.

expert video

Interactions of Type 2 Inflammation on Epidermal Abnormalities: Barrier Dysfunction and Microbial Dysbiosis

23 min

Dermatology

Insights from ESDR 2022 ADVENT symposium, examining how type 2 inflammation impacts skin barrier components and the microbiome in atopic dermatitis.

expert video

Clinical Evidence of Barrier Normalization by Targeting Type 2 Inflammation

28 min

Dermatology

Insights from ESDR 2022 ADVENT symposium, reviewing how targeting type 2 inflammation may improve or normalize the skin barrier in atopic dermatitis.

expert video

Inside Atopic Dermatitis: Type 2 Inflammation Underlies Skin Barrier and Neuroimmune Dysfunction

71 min

Dermatology

Insights from the ESDR 2022 ADVENT symposium, uncovering the role of type 2 inflammation in skin barrier and neuroimmune dysfunction in atopic dermatitis.

expert video

Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children

13 min

Dermatology

Explore WCD 2023 ADVENT symposium's insights into managing short and long-term challenges of pediatric atopic dermatitis.

expert video

Emerging Clinical Data in Children With Atopic Dermatitis

12 min

Dermatology

Explore WCD 2023 ADVENT symposium's insights into current and emerging treatment strategies for managing pediatric atopic dermatitis.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ChinaChange country/region